$12.84 Billion Forecast for Biologics Testing Market by 2029, Backed by Demand and Innovation
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Are the Projected Market Size and Growth Rates for the Biologics Testing Market From 2025 To 2029?
There has been a fast-paced expansion in the size of the biologics testing market in the past few years. It is projected to increase from $5.92 billion in 2024 to $6.83 billion in 2025, with a compound annual growth rate (CAGR) of 15.4%. The overall growth in the past can be linked to the progression in biologics development, stiff regulatory norms, quality control in the process of bioprocessing, an increase in biopharmaceutical investments, and the expansion of the biomanufacturing capacity.
The anticipated expansion of the biologics testing market is quite substantial, with a predicted growth to $12.84 billion by 2029, growing at a 17.1% compound annual growth rate. Various contributing factors for this expected growth include the advent of innovative therapies, the rising demand for third-party testing services, enlarging of biologics strategy, the internationalization of biopharmaceutical manufacturing, and an increased requirement for swift testing solutions. The period of prediction will also see numerous advancements, such as new analytical technologies, cell-based testing methods, next-generation sequencing, quality by design practices, AI integration, and quick product release procedures.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10276&type=smp
What Are the Core Growth Drivers Propelling the Biologics Testing Market Forward?
The swift expansion of the pharmaceutical and biotech sectors is foreseen to bolster the biologics testing market’s growth. The predominant focus of the pharmaceutical industry is the creation and manufacturing of drugs for diverse diseases and health conditions. Conversely, the biotech sector is centered around utilizing technology in the sphere of biology and healthcare. Biologics testing encompasses impurity identification and quantification, stability assessment, and immune response evaluation to the drug. The growing pharmaceutical and biotech sectors have sparked progress in biologics testing technology, including the advent of novel analytical instruments and methods. This has paved the way for more precise and effective testing, decreasing the duration and expenses involved in introducing new biologics to the market. For example, Eurostat, a governing body based in Belgium, stated in July 2024 that pharmaceutical production in the EU rose from €36 billion ($39.4 billion) in 2021 to €44 billion ($46.7 billion) in 2023, indicating considerable growth in the industry. Hence, the swiftly expanding pharmaceutical and biotech sectors are fueling the growth of the biologics testing market.
What Segment Types Define the Biologics Testing Market Structure?
The biologics testingmarket covered in this report is segmented –
1) By Product: Reagents And Kits; Instruments; Other Products
2) By Test Type: Endotoxin Test; Sterility Test; Mycoplasma Tests; Bioburden Tests; Residual Host-Cell Proteins And DNA Detection Tests; Virus Safety Test; Other Test Types
3) By Application: Vaccine Development And Manufacturing; Monoclonal Antibodies Development And Manufacturing; Cellular And Gene Therapy Products Development And Manufacturing; Blood And Blood Products Development And Manufacturing; Other Applications
Subsegments:
1) By Reagents And Kits: ELISA Kits; PCR Kits; Cell Culture Reagents; Other Assay Kits
2) By Instruments: Spectrophotometers; Chromatography Systems; Microplate Readers; Other Analytical Instruments
3) By Other Products: Software; Consumables; Reference Standards
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=10276&type=smp
Which Geographic Areas Hold the Strongest Growth Potential in the Biologics Testing Market?
North America was the largest region in the biologics testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global biologics testing market duirng the forecast period. The regions covered in the biologics testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Which Emerging Trends that Are Influencing theBiologics Testing Industry Evolution?
One emerging trend in the biologics testing market is the evolution of product innovations. Firms in the field are embracing new inventive products to maintain their market share. As an example, Charles River Laboratories International, Inc., a non-clinical contract research organization based in the United States, introduced the Endosafe Nexus 200 in December 2022, broadening its endotoxin testing product line. This completely robotic, data integrity compliant instrument represents the next level in Charles River’s progression. The Nexus 200 utilizes Endosafe Limulus Amebocyte Lysate (LAL) cartridge technology and is adept at handling simple or intricate serial dilutions for water, in-process, and end product testing. Powered by Endosafe EndoScan-V version 6.1, the system allows for data export into a Laboratory Information Management System (LIMS) interface and provides improved traceability, security, and data management through an integrated touchscreen.
View the full report here:
https://www.thebusinessresearchcompany.com/report/biologics-testing-global-market-report
What Is the Definition of the Biologics Testing Market?
Biologics testing typically consists of a range of services aimed at evaluating the safety, efficacy, and quality of biological products.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10276
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
